ReviewFrontiers in immunology2026
The neuroimmune axis in cardiovascular disease: from immune activation to inflammatory resolution.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases (CVDs) are driven not only by hemodynamic and metabolic stress but also by persistent sterile inflammation and defective resolution. Neuroimmune regulation has emerged as an important focus in cardiovascular research. In this review, we synthesize current evidence on the neuroimmune axis in CVDs and highlight how dysregulated autonomic immune communication promotes persistent inflammation, defective resolution, and adverse cardiovascular remodeling. We further emphasize that the neuroimmune axis may influence not only inflammatory activation but also the transition toward resolution and tissue repair, with its effects likely depending on disease stage and inflammatory context. Targeting neuroimmune pathways may help restore the temporal control of inflammation and promote cardiovascular resolution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.